Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 0 | 0 | 9,467 | 0 | 0 |
| Gross Profit | N/A | N/A | 9,467 | N/A | N/A |
| Operating Expenses | 28,939 | 28,670 | 24,813 | 18,228 | 16,601 |
| Operating Income | -28,939 | -28,670 | -15,346 | -18,228 | -16,601 |
| Other Income | 1,371 | 801 | 637 | 333 | 251 |
| Pre-tax Income | -27,568 | -27,869 | -14,709 | -17,895 | -16,350 |
| Net Income Continuous | -27,568 | -27,869 | -14,709 | -17,895 | -16,350 |
| Net Income | $-27,568 | $-27,869 | $-14,709 | $-17,895 | $-16,350 |
| EPS Basic Total Ops | -0.85 | -0.94 | -0.51 | -0.66 | -0.65 |
| EPS Basic Continuous Ops | -0.85 | -0.94 | -0.51 | -0.66 | -0.65 |
| EPS Diluted Total Ops | -0.85 | -0.94 | -0.51 | -0.66 | -0.65 |
| EPS Diluted Continuous Ops | -0.85 | -0.94 | -0.51 | -0.66 | -0.65 |
| EBITDA(a) | $-29,269 | $-28,845 | $-15,467 | $-18,216 | $-16,608 |